Pharmicell

파미셀(주) · KOSPI · 005690 · Industry: Manufacture of electronic components

Key metrics

Earnings

Revenue, Q3 2026₩37.0bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-5.2% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+44.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026₩11.9bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ-9.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY+46.6% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩39.6bn As of Oct 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5
Supply contracts vs prior-year revenue34.7% As of Oct 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months3 As of Nov 19, 2026
DART filings, previous 3 months13 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)14,000 shares As of Jan 28, 2026 Source 1 ↗
Open-market buys, last 12 months (amount)₩194m As of Jan 28, 2026 Source 1 ↗
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)14,000 shares As of Jan 28, 2026 Source 1 ↗
Insiders who bought, last 12 months1 As of Jan 28, 2026 Source 1 ↗

Insider transactions (last 12 months)

Open-market buys: 14,000 shares (₩194m). Open-market sells: 0 shares (₩0). Net open-market buying: +14,000 shares. Insiders who bought: 1.

Trade dateInsider (role)TypeSharesPriceAmount
Jun 16, 2026Kim Su-chan (Registered director)Other (Other increase)+668 shares——
Jun 16, 2026Jung Sun-ung (Non-registered officer)Other (Other increase)+668 shares——
Jun 16, 2026Jang Hak-sun (Non-registered officer)Other (Other increase)+668 shares——
Jun 16, 2026Lim Yeong-ja (Non-registered officer)Other (Other increase)+668 shares——
Jun 16, 2026Bae Ui-han (Non-registered officer)Other (Other increase)+668 shares——
Jun 16, 2026Sung Hyeon-sul (Non-registered officer)Other (Other increase)+668 shares——
Jan 28, 2026Kim Hyeon-su (Registered director)Open-market buy+14,000 shares₩13,831₩194m
Jan 13, 2026Sung Hyeon-sul (Non-registered officer)Other (New appointment)+978 shares——

Annual financials

YearRevenueOperating income
2025₩114.1bn₩34.3bn
2024₩64.9bn₩4.7bn
2023₩56.2bn₩1.3bn

Filing timeline